Overview

• Influential expert panel gave its highest recommendation to expanded menu of H.I.V. prevention strategies for adults and adolescents.
• Recommendation requires private insurers to cover the drugs without co-pay or deductible under Affordable Care Act.
• Panel recommended three medications approved for pre-exposure prophylaxis (PrEP): Truvada, Descovy, and cabotegravir.
• New options may cost over $20,000 per year.
• In 2020, nearly 31,000 people acquired H.I.V., with majority of cases among adolescent and adult men who have sex with men.